Breakthrough study unveils promising drug treatment targets for alcohol-related liver disease

Updated:5 years, 5 months ago

New Delhi, May 25 (ANI): Two promising molecular targets for Alcohol-related liver disease (ALD) drug development, has been uncovered by researchers from the Massachusetts General Hospital (MGH), in a breakthrough study. ALD is a deadly condition affecting more than 150 million people worldwide with no treatment available besides transplant. Published in Proceedings of the National Academy of Sciences (PNAS), the research was achieved by combining RNA sequence analysis of patient liver samples with transgenic mouse studies. The team uncovered two key molecular step stones in ALD that may provide targets for drug therapy development - cGAS and Cx32. "Now that we know the key players in this pathway, we finally have drug targets for treatment development," said Jay Luther, lead author of the study and also the MD, gastroenterologist, and Director of the Mass General Alcohol Liver Center. Researchers already knew that liver cell (hepatocyte) death in ALD is driven by IFN regulatory factor (IRF3). That process also fuels a strong secondary inflammatory response that affects nearby cells and can eventually lead to liver failure. But scientists have been puzzling over how alcohol activates IRF3 and which pathways amplify the inflammatory signals that make the disease spread throughout the liver. As a result of that process, ALD attacks the liver at a certain point regardless of whether the patient is still drinking alcohol. "Until now, now we had only a few clues about why the alcohol-related liver disease progresses the way it does, but this research fills in key pieces of the puzzle," noted senior author is Suraj J. Patel, MD, PhD, a research fellow in the Department of Medicine. In their studies, the team analyzed liver cells from patients, with a wide range in degree of disease severity, using RNA-sequencing. Their analysis showed that the level of cGAS expression was related to the degree of disease. In a study of alcohol-fed mice, they found those animals also had higher expression of the cGAS-IrF3 pathway in liver cells. Meanwhile, mice that were genetically designed to have lower levels of cGAS and IRF3 were less susceptible to ALD. The Mass General-led team determined that cytoplasmic sensor cyclic guanosine monophosphate-adenosine monophosphate (AMP) synthase (cGAS) drives IRF3 activation in both liver cells directly injured by alcohol as well as neighbouring cells. They also pinpointed connexin 32 (Cx32) as a possible new drug target, as it is a key regulator of cGAS-driven IRF3 activation. "It is very encouraging to see that we now have evidence-based targets for drug development for ALD," added Luther.

Breakthrough study unveils promising drug treatment targets for alcohol-related liver disease

Top Videos

Related Video

Breakthrough study unveils promising drug treatment targets for alcohol-related liver disease

Top Videos

Related Video

Aggressive intervention recommended to prevent pediatric diabetes, finds study

Study reveals high fat diets may over-activate destructive heart disease protein

Consuming diet high in poor quality carbohydrates linked to heart attacks, death risk

Researchers find light activities may help women's mobility during ageing

COVID antibodies are transferred from pregnant women to their babies

Overweight, diabetic people at risk of developing nonalcoholic fatty liver disease

Study reveals factors linked with elevated risk of bone fracture

Damage to heart found in more than half of COVID-19 patients discharged from hospital

LGB people more prone to mental health disorders, alcohol misuse

Unacceptably high levels of carcinogens inhaled by commuters

Post-surgery in kids, aspirin preferred to prevent blood clots

Coffee consumption related with decreased heart failure risk

Study reveals high blood pressure causes atrial fibrillation

Greater retail availability of marijuana, alcohol linked with co-use among teens

COVID-19 patients have higher risk of dying after cardiac arrest

World Cancer Day: Understanding role of nutrition, lifestyle changes to control cancer

Pregnancy complications increase risk of heart disease in women

Antibiotic may improve depressive symptoms in people with low-level inflammation: Study

Serious complications during pregnancy linked to higher risk of death: Study

Study reveals what causes irritable bowel syndrome